a number of clinical trials have shown that the daily use of aspirin 160 to 325 mg daily , dipyridamole 300 to 400 mg daily , or both are effective in preventing platelet aggregation , and results in a statistically significantly reduction in the incidence of coronary events and transient ischemic cerebral attacks .
C0004057
aspirin
C0007787
transient ischemic